Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Kiniksa Pharmaceuticals, GmbH
- Target Recruit Count
- 3
- Registration Number
- NCT06531395
- Locations
- 🇺🇸
Medvin Clinical Research, Whittier, California, United States
🇺🇸BioSolutions Clinical Research Center, Poway, California, United States
🇺🇸International Medical Research, Daytona Beach, Florida, United States
News
No news found